Modern Diagnostic & Research Centre Limited Board Approves Equipment Upgrade and Operational Changes
Modern Diagnostic & Research Centre Limited's board meeting on March 09, 2026, approved strategic operational changes including equipment upgrade from SPECT to SPECT-CT at Gurugram facility, vendor changes for construction works outside Delhi, and new banking arrangements with Axis Bank and Standard Chartered Bank. The board also authorized comprehensive document execution powers and approved location changes for laboratory operations within Delhi.

*this image is generated using AI for illustrative purposes only.
Modern Diagnostic & Research Centre Limited announced significant operational and infrastructure decisions following its Board of Directors meeting held on March 09, 2026. The 15-minute board meeting, which commenced at 01:30 P.M and concluded at 01:45 P.M, addressed multiple strategic initiatives aimed at enhancing the company's diagnostic capabilities and operational efficiency.
Equipment and Infrastructure Upgrades
The board approved a major equipment specification change at the company's Sector-40 Gurugram facility, upgrading from SPECT to SPECT-CT technology. This enhancement represents a significant advancement in the company's diagnostic imaging capabilities.
| Decision Area: | Details |
|---|---|
| Equipment Upgrade: | SPECT to SPECT-CT at Sector-40 Gurugram |
| Vendor Change: | Building, electrical and air-conditioning works |
| Scope: | Diagnostic Centre and laboratories outside Delhi |
| Location Change: | Laboratory within Delhi (new location) |
Banking and Financial Arrangements
The board authorized several banking-related decisions to support the company's operational expansion. Key approvals included opening a new bank account and transferring loans to Axis Bank, Gurugram. Additionally, the board approved opening another bank account with Standard Chartered Bank, as proposed by the chairperson.
Operational Authorizations
The board granted comprehensive authorization for executing various legal, tender, lease/rent, and miscellaneous documents on behalf of the company. This authorization extends to conducting sales/purchases and entering into contracts, providing management with enhanced operational flexibility.
Regulatory Compliance
The decisions were made in compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting outcome was communicated to BSE Limited, where the company is listed under scrip code 544673. Managing Director Devendra Singh Yadav (DIN: 01254395) signed the regulatory filing, which was digitally authenticated on March 09, 2026.
























